Repair+ Stack (BPC-157 · TB-500 · KPV vials)

Mass equivalence is not molar equivalence

A 10/10/10 mg blend of these three peptides is not an equimolar preparation. KPV at 342 g/mol contributes roughly four times as many molecules per milligram as BPC-157 at 1,420 g/mol. For receptor or pathway work where molar concentration is the meaningful variable, that gap matters, and only separate vials allow it to be corrected.

BPC-157

TB-500

TB-500 corresponds to the actin-binding region of thymosin beta-4, a peptide found broadly in mammalian tissue. In-vitro studies have examined actin sequestration and the migration of endothelial cells and keratinocytes, typically in scratch-assay or transwell formats, which is why it pairs so often with BPC-157 in repair-model designs.

KPV and inflammatory signalling

KPV has been studied in cell and rodent models of intestinal inflammation. Published interest centres on NF-κB pathway activity and on transport of the tripeptide across epithelial cells, including work on peptide transporter involvement. It is the component that distinguishes this kit from a two-peptide repair pairing.

What the evidence does not show

Prepare each vial individually and label it at once, since all three give clear colourless solutions that are indistinguishable by eye. Bring the vial to room temperature, wipe the stopper with alcohol, add bacteriostatic water slowly against the inner wall and swirl gently until dissolved rather than shaking. KPV dissolves quickly given its small size; the two larger peptides may need a little longer. Keep unopened vials sealed at −20 °C, refrigerate reconstituted material at 2–8 °C protected from light, and record the preparation date on every label.